Search
for
Sort by
Research 391–420 of 1000+
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- Recalcitrant alopecia areata responsive to leflunomide and anthralin—Potentially undiscovered JAK/STAT inhibitors?
- Balance of tofacitinib efficacy and disease flare in the treatment of alopecia universalis: A case report and review of the literature
- Irreversible alopecia universalis during treatment with pegylated interferon-ribavirin for chronic hepatitis C virus infection: Case report and published work review
- The role of vasoactive peptides in skin homeostasis—focus on adiponectin and the kallikrein-kinin system
- Treatment of Severe Alopecia Areata: Combination Therapy Using Systemic Cyclosporine A with Low Dose Corticosteroids
- Evaluation of SALT score severity in correlation with trichoscopic findings in alopecia areata: a study of 303 patients
- Differential effects of Wnt5a on the proliferation, differentiation and inflammatory response of keratinocytes
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Combination Therapy with Baricitinib and Narrowband Ultraviolet B for Active Non-Segmental Vitiligo: A Retrospective Controlled Study
- Oxidative stress and alopecia areata
- Increase in IL-15 levels in patients with alopecia areata
- Correlation between serum granulysin level and clinical activity in patients with alopecia areata before and after tofacitinib therapy
- Dystrophic-Anagen Effluvium Occurring During Pegylated Interferon-α-2a/Ribavirin Therapy
- Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report
- ROS-scavenging microneedles loaded with <i>Portulaca oleracea</i> L.-derived exosomes for atopic dermatitis therapy
- Mechanism of PPARα agonist in alopecia areata
- Leflunomide: an unlikely trigger and mechanistically a beneficial drug for alopecia areata
- The role of vitamin D in alopecia areata
- British Cosmetic Dermatology Group
- Serum prolactin levels in dermatological diseases: A case–control study
- Sentinel lymph node status is the strongest independent predictor for disease free and overall survival in patients with thick melanoma
- MicroRNA-mediated regulation of hair follicle regeneration: mechanisms, delivery strategies, and translational perspectives
- Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review
- Metabolic syndrome in Iraqi patients with Alopecia areata: A case control study
- Exploring the association between alopecia areata and thyroid dysfunction: A review
- TYK2 Inhibition with Deucravacitinib Improves Clinical Outcomes and Resolves Interferon-Driven Inflammation in Lichen Planopilaris
- Upadacitinib for the Treatment of Systemic Immune Co-Morbidity in One Case: Alopecia Areata, Vitiligo, Ankylosing Spondylitis, and Allergic Rhinitis-Asthma – Multifaceted Control
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Catechins-rich tea extract and its functional properties mitigating hair loss